TenSixteen Bio Funding: $40M Raised, Series A (2022)

TenSixteen Bio funding overview

TenSixteen Bio has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for TenSixteen Bio runs through 2022; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Foresite Capital, GV, Mithril Capital Management, Polaris Partners, RA Capital. 6 distinct backers are named across the disclosed rounds.

TenSixteen Bio at a glance

Total raised: $40M
Latest round: Series A
Latest round date: January 2022
Notable investors: ARCH Venture Partners, Foresite Capital, GV, Mithril Capital Management, Polaris Partners, RA Capital

Frequently asked about TenSixteen Bio funding

How much has TenSixteen Bio raised?: TenSixteen Bio has raised $40M in total disclosed funding across the rounds on record.
Who has invested in TenSixteen Bio?: ARCH Venture Partners, Foresite Capital, GV, Mithril Capital Management, Polaris Partners, RA Capital are named among the investors backing TenSixteen Bio.
What was the latest TenSixteen Bio funding round?: The most recent disclosed round is a Series A, announced in January 2022.
Where is TenSixteen Bio based?: No headquarters location is disclosed for TenSixteen Bio.
When did TenSixteen Bio last raise?: The last disclosed TenSixteen Bio round closed in January 2022 at Series A.

Round data for TenSixteen Bio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.

TenSixteen Bio Funding: $40M Raised, Series A (2022)

TenSixteen Bio funding overview

TenSixteen Bio at a glance

Frequently asked about TenSixteen Bio funding

Companies related to TenSixteen Bio (18)

Browse related funding lists (7)